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Case Report
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Abstract

Case Presentation

Thymomas are rare malignant epithelial growths,
constituting 20% of mediastinal tumours. Resection
followed by irradiation may be employed in all thymomas
except for stage 1 thymomas. Mediastinal irradiation is
associated with coronary artery disease. The mean
duration of presentation of post-irradiation coronary artery
disease is 16 years (range 3-29 years). In our patient
coronary artery disease was found only a year post
irradiation. A 55 year old male who presented with
complaints of dyspnoea, retrosternal chest pain and
heaviness since one year underwent resection for
malignant thymoma followed by radiotherapy. He
presented with coronary artery disease a year after
undergoing mediastinal irradiation. On follow-up, patient
was treated successfully by coronary artery bypass graft.
This case is an unusual occurrence and suggests that
mediastinal irradiation may result in significant coronary
artery disease as early as within one year.

A 55 year old male presented with complaints of
dyspnoea, retrosternal chest pain and heaviness since one
year. He was a known hypertensive and ex-smoker. His
cardiac work up was unremarkable and revealed a normal
thallium scan. He then underwent a chest roentgenogram
which showed widening of the mediastinum. This finding
was suggestive of either a mediastinal mass or
lymphadenopathy. Computed tomography (CT) scan was
carried out which gave indications of a large soft tissue
mass located in the mediastinum, spanning from just above
the aortic arch to the level of the heart, with dimensions of
8 x 9 x 9.5 cm. This was followed by a trans-esophageal
echocardiogram that revealed an echogenic mobile density
at aortic root which appeared to be secured with the left
coronary cusp of the aortic valve. On further analysis it was
concluded to be a vegetative mass. The left ventricle was
found to be of normal size and reported to have a normal
ejection fraction. Electrocardiography (ECG) recordings
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Introduction
Thymoma is a neoplasm of the thymus originating
in the gland's epithelial tissue. It is a slow-growing tumour
that spreads by local extension. Metastases are usually
confined to the pleura, pericardium, or diaphragm,
whereas extrathoracic metastases are uncommon.
Resection followed by irradiation may be employed in all
thymomas except for stage I thymomas.1 Degree of
encapsulation and invasion of adjacent structures in
thymomas are significant in defining malignancy.2
Mediastinal irradiation is associated with coronary artery
disease (CAD) as well as damage to various cardiac
structures such as the pericardium, myocardium, heart
valves and the aorta.3-7 The mean duration of presentation
of post-irradiation CAD is 16 years (range: 3-29 years).6
We present a case of a male patient who presented with
CAD only a year after undergoing resection of thymoma
and mediastinal irradiation.
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Figure-1: The figure displays the tumour, sparing the vagus nerve.
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were unremarkable. The laboratory results were within
normal ranges with, serum alpha fetoprotein level of
3.55ng/mL, Beta- HCG of <2mU/ml and serum HDL of
1.96mmol/L.
Further exploration of the nature of mass was done
by means of three procedures; bronchoscopy, videoassisted thoracoscopy (VATS) and biopsy. While
bronchoscopy confirmed normal airways, VATS and biopsy
established the presence of a thymoma.
On account of the above information, resection of
the mass was planned. After induction of general
anaesthesia, median sternotomy was performed. A large
mass encasing the innominate vein was identified in the
anterior and superior aspect of the mediastinum.The mass
was found to be in close approximation of the pericardium,
left phrenic nerve and the vagus nerve with the fibrous
pericardium adherent to serous pericardium.
The tumour was found to be extending medially
towards the left upper lobe of the lung, sparing the hilum,
ribs and sternum. The tumour along with the anterior aspect
of the pericardium, fastened closely with the innominate
artery and vein, left carotid artery and the arch of aorta was
removed. The left phrenic nerve which was masked by the
tumour had to be sacrificed. The vagus nerve was unharmed
(Figure-1). The dimensions of the tumour was 10x12cm
(Figure-2).
Histopathological analysis of the specimen revealed
a mixed type B2 invasive thymoma.

Figure 2: This figure displays the thymoma with dimensions of 10cm X 12 cm.
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Tumour resection was followed by radiation therapy
of a dose of 5400 centigray (cGY) over a length of one and
a half month. The patient remained free of symptoms for
one year after which he presented with complaints of chest
pain exacerbating on exertion. Exercise tolerance test was
performed which revealed alterations in ECG. Angiography
was carried out which unveiled three-vessel CAD. The mid
and distal segments of the right coronary artery were 100%,
left circumflex artery was 70-80% and left anterior
decending artery was 70-90% occluded.
A Coronary Artery Bypass Graft (CABG) was
planned and performed. Four saphenous vein grafts were
employed (first on obtuse marginal one, second on posterior
descending and two sequential grafts on the left anterior
descending artery). The patient made good recovery and
was discharged 7 days post-surgery. Four years follow up
and CT angiography findings have indicated patent grafts.
Currently, the patient is healthy and has not had recurrence
of a thymic tumour.

Discussion
Thymic tumours form a class under common
anterior mediastinal tumours.2 Thymoma refers to a
malignancy originating from epithelial cells of thymus. It
constitutes 20% of the tumours of mediastinum accounting
for about 50% of the tumours in adults. It has an incidence
of 0.15 cases per 100,000.8 Often, thymoma is considered to
have a docile growth pattern but it does have the ability to
give rise to local invasion and intrathoracic recurrences.8
The treatment of choice for thymomas is complete resection
whenever possible. Resection is associated with low
mortality and morbidity.Simple enucleation of a thymoma is
not highly recommended because it may result in
recurrence. This is elucidated by the possibility that nonresected thymic tissue can act as a potential site for future
development of an additional thymoma or it can result in the
presence of multiple small lobules of tumours not detectable
on gross examination at the start of operation.2
In non-invasive thymoma (stage I), post-operative
radiation therapy is not essentially required. This has been
reaffirmed because of evidence put forward by studies
which explain that incidence of recurrence has been low
even without radiation therapy.8,9 On the contrary,
recurrence rates for completely resected invasive thymomas
are higher and hence warrant irradiation along with
resection to prevent local relapse.9,10 The recommended
dose of radiation therapy ranges from 30 to 60 Gy in 1.8 to
2.0 cGy fractions over a span of three to six weeks.
Treatment fields and dose fractions should be arranged and
monitored to minimize complications. Treatment portals
may include single anterior field, unequally weighted (2:1
or 3:2) opposed anterior-posterior fields, wedge-pair, and
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multifield arrangements.9
The incidence of radiation induced injury is 5% to
30%. Mediastinal irradiation toxicity depends on the
amount of normal tissues included within the radiation
portal and can result in a wide variety of injuries ranging
from minor fibrosis to heavy scarring and fusion of the
mediastinal structures. Extensive pericardial, myocardial,
vascular, and valvular damage can also occur along with the
aortic arch and great vessels.5 Amongst possibility of
incurring the injury, the most commonly involved structure
is pericardium while the structure least likely to be damaged
is the conduction system. Many patients treated with
radiation therapy for thoracic malignancies survive the
malignancies but become susceptible to early development
of ischaemic heart disease with the majority not having
classic risk factors for the development of CAD.4
In case of CAD, the distribution of lesions correlate
with the radiation dosimetry. Irradiation may cause
pathological intimal denudation leading to intimal damage
and thrombus formation. Radiations may lead to fibrosis
and cell proliferation, after damage to media. These
mechanisms may contribute to coronary atherosclerosis and
cause early failure of venous grafts in case of CABG.
Accelerated atherosclerosis occurs in irradiated arteries and
this leads to impaired patency of grafts.7
Performance of CABG in a patient with history of
irradiation is challenging because of severe mediastinal and
pericardial fibrosis. Surgeons may be reluctant and cautious
about using internal thoracic artery as a site of intervention
for myocardial revascularization in patients with a history
of thoracic radiotherapy. The reason being that irradiation
may result in sclerosis of connective tissue surrounding the
internal thoracic artery.7 While performing CABG in our
patient internal thoracic artery was not used, instead two
sequential reverse saphenous vein grafts were placed on the
left anterior descending artery.
One limitation needs to be addressed. Since the
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initial cardiac workup included thallium scan only and
coronary angiography was not performed, pre-existing
non-significant CAD could not be completely ruled out.
Hence, had that been the case, radiation might have
accelerated the progression of pre-existing CAD rather
than causing it.

Conclusion
In conclusion, our patient presented with CAD in only
a year post radiation, while the mean time period from
mediastinal irradiation to development of CAD is 16 years
(range 3-29 years).6 Hence, this case is an unusual occurrence
and suggests that mediastinal irradiation may result in
significant coronary artery disease as early as within one year.
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